Life Insurance
Consensus Index

AI Consensus Fit Review

Securian Financial Indexed Universal Life Insurance Fit Review for $2 Million or More in Coverage

Securian Financial is a qualified but not conclusively best fit for a healthy high-income buyer seeking $2 million or more of indexed universal life coverage.

Research: 2026-09-217 usable platform responsesRead the methodology ↗

Share

Answer Capsule

Securian Financial is a qualified but not conclusively best fit for a healthy high-income buyer seeking $2 million or more of indexed universal life coverage. Four of the seven platforms in this study named Securian during the ranking stage, and six of seven returned a usable fit assessment. The strongest reason to consider it is the combination of reported A+ (Superior) financial strength, documented large-face-amount underwriting experience, and the Eclipse Accumulator II IUL's accumulation-oriented, low-charge design. The main limitation is that no public source verifies a $2 million-plus issue limit, case-specific pricing, or current cap and participation rates for the exact plan, so buyers must verify capacity, charges, and state availability before applying.

Research Snapshot

FieldFinding
Platform mentions in ranking stage4 of 7 platforms (anthropic, deepseek, google, perplexity)
Share of included platform responses57.1%
Average listed rank6.75
Best listed rank5 (perplexity)
Relevant product/model/planEclipse Accumulator II IUL; current state-specific policy form and issuing entity must be confirmed
Overall use-case fitGood, subject to substantial verification
Research date2026-09-21

Why Securian Financial Qualified for This Study

Questions This Section Answers

  • Is Securian Financial a good choice for Indexed Universal Life Insurance for $2 Million or More in Coverage?
  • Why did AI platforms include Securian Financial in a $2 million IUL carrier ranking?
  • How many AI platforms named Securian Financial for large-face indexed universal life coverage?

Securian Financial qualified because four of the seven platforms in this study named it during ranking discovery, and six of seven returned a usable fit assessment for this use case. Its inclusion rests on three supplied findings: a real indexed universal life lineup, reported financial strength, and documented large-face underwriting experience.

The product line is verifiable. Securian markets indexed universal life through financial professionals, and the Eclipse Accumulator II IUL is described as a single-life, accumulation-focused policy built around transparent charges and multiple indexed accounts [1].

Financial strength is the most consistently reported advantage. Securian reports high ratings for Minnesota life insurance Company and Securian Life Insurance Company with a Comdex ranking of 95 as of June 1, 2026 [5]. AM Best affirmed an A+ (Superior) insurance financial strength rating with a stable outlook, and the company states it has held an A or higher rating for 75 years [6]. Independent reporting describes Securian as the seventh-largest life insurance company in the United States with more than $1.7 trillion of life insurance in force [9].

Large-face capability is company-documented. Securian states it specializes in underwriting large-face-amount cases, requires third-party financial documents above $10 million (or above $1 million for applicants age 70 and older), and uses reinsurance for large applications [11].

The ranking-stage position was mid-pack, not top-tier. Securian's average listed rank was 6.75, with a best rank of 5 from perplexity and a rank of 10 from anthropic. That spread matters: platform agreement on inclusion does not establish that Securian is the best carrier for this use case.

The Product, Model, Plan, or Service Most Relevant to Indexed Universal Life Insurance for $2 Million or More in Coverage

Questions This Section Answers

  • Which Securian Financial plan should a buyer choose for $2 million or more of indexed universal life coverage?
  • What is the minimum face amount on Securian Eclipse Accumulator II IUL, and can it reach $2 million?
  • Is Securian Eclipse Accumulator II IUL available in my state?

The most relevant plan is Eclipse Accumulator II IUL, a flexible-premium, accumulation-focused indexed universal life policy. Buyers should treat the exact current policy form, issuing entity, and state availability as unconfirmed until verified.

Published product mechanics include a $100,000 minimum face amount, level or increasing death-benefit options, fixed and indexed account choices, and a 0% crediting floor [14]. The product offers five indexed account options with a 0% floor and point-to-point annual reset, including both capped and uncapped account designs [15].

The $100,000 published minimum is a floor, not a large-face limit. No supplied source verifies a $2 million minimum or a maximum issue amount for Eclipse Accumulator II IUL specifically. One Securian IUL contract, Value Protection IUL, carries a $5 million maximum face amount, which shows some Securian IUL contracts support very large face amounts but does not confirm the Accumulator II limit [18].

Geographic availability is restricted. Eclipse Accumulator II IUL is reported as available in all states except California, Florida, Oregon, and New York, with the predecessor Eclipse Accumulator continuing in some of those states until the II version is approved; the product line is not available in New York [19]. One source reports the Accumulator II became available in Oregon on March 30, 2026, which conflicts with the broader "not available in Oregon" statement and should be verified for the buyer's state [23].

Securian also offers Eclipse Survivor II, a second-to-die policy for couples that is commonly used for estate planning and legacy transfer [24]. For a $2 million-plus estate or legacy case, that structure may be more relevant than a single-life policy.

What the AI Platforms Agreed About

Questions This Section Answers

  • What do AI platforms agree on about Securian Financial for $2 million indexed universal life coverage?
  • Is Securian Financial financially strong enough for a $2 million permanent policy?

Platforms agreed on financial strength, product existence, and large-face underwriting orientation. They did not agree on pricing competitiveness or on whether Securian is the best choice.

Financial strength drew the strongest and most consistent support. Securian reports high ratings from AM Best, Fitch, Moody's, and S&P with a Comdex ranking of 95 as of June 1, 2026 [28]. AM Best affirmed A+ (Superior) with a stable outlook and assessed risk-adjusted capitalization at the strongest level [29]. Independent reporting corroborates the seventh-largest U.S. life insurer position and $1.7 trillion in force [32].

Platforms agreed the product is real and accumulation-oriented. Eclipse Accumulator II IUL is described as a flexible-premium IUL with multiple indexed accounts, a 0% floor, and level or increasing death-benefit options [34].

Platforms agreed Securian handles large cases. Company materials state Securian specializes in underwriting large-face-amount cases and uses reinsurance for large applications [37].

Platforms agreed on the charge and lapse caveats. Product disclosures identify mortality and expense charges, premium and policy charges, transaction and index-segment charges, surrender charges, and the possibility of losing money [40]. Loans and withdrawals reduce policy values and death benefits and can create adverse tax consequences if the policy lapses or is surrendered [40].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

  • How much does Securian Financial cost for a $2 million indexed universal life policy, and is it more expensive than competitors?
  • What are the current cap and participation rates on Securian Eclipse Accumulator II IUL?
  • How fast can Securian Financial underwrite a $2 million or larger IUL case?

Platforms disagreed on pricing, on cap-rate transparency, and on how much of the underwriting story is verified. One platform rated the fit uncertain because it could not retrieve Securian-specific product details at all.

Pricing is the sharpest conflict. Securian markets the product with emphasis on low charges and competitive illustrated rates [44]. Independent sources report a perception that Securian IUL pricing runs up to 15% higher than some competitors, and one source cites concerns about steep fees [47]. No formal independent pricing benchmark was located, so the cost comparison is unresolved.

Cap and participation rates are not publicly disclosed. Specific current cap rates and participation rates appear to be available only through a financial professional portal, and parameters may change by segment, state, and issue date [49]. One platform reported a maximum illustrated rate of 6.59% and a 2% lifetime minimum guarantee, but that is platform-reported and not confirmed in the supplied company materials [51].

Underwriting speed is partly verified. WriteFit accelerated underwriting is reported to allow approval within 24 hours for healthy applicants ages 0-54 at up to $2 million without a medical exam, which one independent review calls significantly higher than most carriers' no-exam limits [52]. What is not verified is turnaround for amounts above $2 million, which require traditional underwriting with medical evidence.

Surrender period length conflicts. One platform reports a 15-year surrender period on Eclipse Accumulator II IUL, while another reports surrender charges in the first 10 years [56]. Buyers should confirm the exact schedule for the proposed policy form.

One platform could not verify Securian at all. Kimi rated the fit uncertain because its retrieved sources covered Pacific Life, John Hancock, Prudential, and Principal rather than Securian, and it could not confirm product names, ratings, or charges [58]. That is a retrieval gap, not evidence that Securian lacks these capabilities.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What features make Securian Eclipse Accumulator II IUL suitable for a $2 million permanent policy?
  • Does Securian Financial offer policy loans and estate planning structures for large IUL policies?

The features most relevant to a $2 million-plus buyer are indexed-account design, policy loan flexibility, large-case underwriting infrastructure, and a second-to-die option for estate planning.

Indexed-account design. The product offers five indexed account options with a 0% floor and point-to-point annual reset, including capped and uncapped designs [61]. The 0% floor limits index-driven losses but does not prevent policy value from declining, because charges and other deductions continue [64].

Policy loan flexibility. The Eclipse Accumulator line offers four loan options including fixed, indexed, variable, and 90-day interest-free short-term loans, and indexed loans allow borrowed funds to continue participating in index-linked growth [66]. Indexed loans are tied to the Indexed Loan Agreement and are not available on every IUL contract [68].

Large-case underwriting infrastructure. Securian states it specializes in underwriting large-face-amount cases, requires signed third-party financial documents above $10 million (or above $1 million for applicants age 70 and older), and recommends underwriter review before application completion when a potential sale exceeds $10 million [69]. Premium affordability is assessed against income, with Securian able to consider premium up to 20% of income for most applicants [73].

Estate and legacy structures. Eclipse Survivor II is a second-to-die policy covering two lives, designed for estate planning and legacy transfer, and couples often find insuring two lives on one policy costs less than two separate policies [74].

Accelerated underwriting. WriteFit provides a phone-interview-only path to $2 million for healthy applicants ages 0-54, with approval reported in as little as 24 hours [79]. This is the single most concrete operational advantage for a buyer whose target face amount sits exactly at $2 million.

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does Securian Financial cost per month for a $2 million indexed universal life policy?
  • What fees and surrender charges apply to Securian Eclipse Accumulator II IUL?
  • Are Securian Financial's IUL charges competitive with other large-face carriers?

No public, buyer-specific premium quote exists for a healthy individual seeking $2 million or more. Pricing confidence across platforms was low, and the cost comparison against competitors is unresolved.

Disclosed charge categories include cost-of-insurance and other mortality charges; premium, monthly policy, transaction, index-segment, and surrender charges; optional agreement or rider charges; and potential policy-loan interest or loan-spread costs [82]. Charges may increase over time, and policyholders could lose money in the product [85].

Surrender terms conflict across sources. One platform reports a 15-year surrender period after issue or face amount increase, while another reports surrender charges in the first 10 years [85]. Loans and withdrawals reduce policy values and death benefits and can create tax exposure if the policy lapses or is surrendered [82].

Actual cost depends on age, sex, tobacco status, underwriting class, face amount, death-benefit option, premium pattern, riders, policy form, state, and illustrated assumptions [82]. No reliable public price was found for the target buyer profile [82].

The competitiveness question is genuinely open. Securian's own materials emphasize low charges and competitive illustrated rates [90], while independent sources report a perception of pricing up to 15% higher than some competitors without providing a formal benchmark [89]. Buyers should obtain side-by-side illustrations rather than rely on either claim.

Best Suited For

Questions This Section Answers

  • Who is Securian Financial best suited for when buying $2 million or more of indexed universal life coverage?
  • Is Securian Financial a good fit for a healthy applicant under 55 who wants no-exam IUL coverage?

Securian is best suited to healthy, high-income buyers in available states who want accumulation-oriented permanent coverage, value institutional strength, and can work through an experienced life insurance professional.

The clearest fit is a healthy applicant ages 0-54 targeting exactly $2 million who wants to avoid a medical exam. WriteFit provides a phone-interview path to that amount with reported 24-hour approval [93].

A second fit is the buyer who prioritizes carrier stability over lowest cost. Securian reports high ratings across four agencies with a Comdex of 95 and states it has held an A or higher rating for 75 years [96].

A third fit is the estate, business, or legacy buyer who will use a professional to design and stress-test a large policy. Securian's large-case underwriting infrastructure and second-to-die option support that structure [98].

A fourth fit is the buyer who prefers a simpler, transparent charge structure over multiplier-heavy or exotic IUL designs. Securian positions the product around low charges, simplicity, and transparency [101].

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose Securian Financial for $2 million or more of indexed universal life coverage?
  • Is Securian Financial a poor fit for buyers in New York or for coverage above $2 million without a medical exam?

Securian is probably not the best fit for buyers in restricted states, buyers who need more than $2 million without a medical exam, buyers optimizing strictly on lowest cost, and buyers who need guaranteed lifetime coverage with minimal reliance on indexed crediting.

New York is excluded. The product line is not available in New York, and Minnesota Life is not an authorized New York insurer [103]. California, Florida, and Oregon also had restricted or phased availability for the Accumulator II version [105].

Buyers above $2 million lose the accelerated path. WriteFit no-exam approval is capped at $2 million for ages 0-54; higher amounts require medical evidence and traditional underwriting [107].

Applicants age 55 and older lose the fastest pathway. Accelerated underwriting is limited to ages 0-54, which disadvantages older high-net-worth buyers [107].

Price-sensitive buyers should compare carefully. Independent sources report a perception of pricing up to 15% higher than some competitors, and no formal benchmark resolves the question [109].

Buyers who need guaranteed lifetime coverage should look elsewhere. Securian's accumulation product does not carry a no-lapse guarantee, and buyers seeking guaranteed permanent death benefit with minimal dependence on indexed crediting should compare guaranteed universal life or whole life.

When Another Option May Be Better

Questions This Section Answers

  • What is a better alternative to Securian Financial for a buyer who needs guaranteed lifetime coverage?
  • When should a buyer choose a different carrier instead of Securian Financial for a $2 million IUL?

Another option may be better in five situations: guaranteed coverage needs, lowest-cost objectives, restricted-state residency, coverage well above $2 million, and a preference for published cap rates before shopping.

If the primary goal is a guaranteed lifetime death benefit, compare guaranteed universal life or whole life from financially strong mutual or stock insurers, and consider Securian's own Eclipse Protector II, which is positioned differently from the accumulation product.

If the goal is maximum death benefit per dollar, compare competitively underwritten term insurance and permanent coverage separately.

If the buyer is in New York or another restricted state, carriers with broader geographic footprints may fit better.

If the buyer needs coverage well above $2 million with streamlined underwriting, or wants a fully disclosed high-face maximum for easy comparison, another carrier may be easier to evaluate.

If the buyer wants published cap and participation rates before engaging an advisor, Securian's portal-only rate disclosure limits pre-application shopping.

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with Securian Financial before signing a $2 million indexed universal life contract?
  • Which legal insurer will issue the Securian policy, and what are the current cap rates?

Confirm these items in writing before submitting an application.

  • Which legal insurer will issue the policy in the buyer's state: Minnesota Life Insurance Company or Securian Life Insurance Company (official:C1)?
  • What is the exact current policy form and state-specific illustration for Eclipse Accumulator II IUL ?
  • Can the carrier issue at least $2 million, $5 million, or more for this applicant, and what are the current jumbo-case financial and medical underwriting requirements ?
  • What are the guaranteed and current premiums, policy charges, surrender charges, cost-of-insurance rates, and rider charges for the proposed design ?
  • What caps, participation rates, trigger rates, floors, fixed-account rates, and loan-crediting provisions apply at issue, and which are guaranteed [111]?
  • What is the exact surrender charge schedule, and does it run 10 years or 15 years [112]?
  • What happens to the policy under 0%, 2%, and 4% stress-tested crediting assumptions, including premium reductions, missed premiums, loans, and withdrawals ?
  • What are the policy-loan interest rates, loan types, lapse-warning procedures, and consequences of a heavily loaned policy ?
  • Can the buyer obtain an informal underwriting assessment before submitting a formal application, and what medical records and financial documents are required ?
  • How do Securian's charges compare in basis points to the three closest competitor products at the same underwriting class and face amount ?

Final AI Consensus Verdict

Securian Financial is a good fit for Indexed Universal Life Insurance for $2 Million or More in Coverage, subject to substantial verification. Four of seven platforms named it during ranking discovery, and six of seven returned a usable fit assessment. Five platforms rated the fit good or strong; one rated it uncertain because it could not retrieve Securian-specific sources.

The case for Securian rests on reported financial strength, a real accumulation-oriented IUL product, documented large-face underwriting infrastructure, and a concrete operational advantage: WriteFit accelerated underwriting to $2 million for healthy applicants ages 0-54. The case against rests on unverified large-face capacity for the exact plan, no public pricing, portal-only cap-rate disclosure, geographic exclusions, conflicting surrender-period reports, and a mid-pack average ranking position.

Platform agreement on inclusion is not proof of product quality. Buyers should obtain a state-specific illustration, written confirmation of $2 million-plus issue capacity, the full charge schedule, and competing illustrations from at least two other carriers before committing.

How This Review Was Produced

This review synthesizes fit assessments returned by seven AI platforms for a single buyer prompt: a healthy high-income consumer seeking at least $2 million of indexed universal life insurance for permanent family, estate, business, or legacy needs. Platforms were asked which life insurance carriers they would recommend and why.

Securian Financial qualified for this study because it was named by at least two platforms during ranking discovery. Four of seven platforms named it: anthropic, deepseek, google, and perplexity. Six of seven returned a usable fit assessment. Google named the entity during ranking but did not return a fit assessment used in this review.

Platform fit ratings were: anthropic good, deepseek good, grok strong, kimi uncertain, openai good, and perplexity good. Ranking positions varied widely, from 5 (perplexity) to 10 (anthropic), producing an average listed rank of 6.75.

All factual claims in this review are drawn from the supplied platform responses and their cited sources. Citations are platform-reported evidence, not independently verified facts. Company-owned citations materially outnumber independent citations in the supplied material, so company claims should not be read as independently confirmed.

Methodology Limitations

Several limitations apply to this review.

Six of seven included platforms returned a usable fit assessment, so the fit findings are not unanimous and should not be described as such. Platform mentions in the ranking stage count only platforms that named the entity during ranking discovery.

Platform-reported research dates differ from the authoritative study date of 2026-09-21. DeepSeek reported a research date of 2026-06-11, and its search was disabled, meaning its findings are model-reported rather than retrieved. Platform-reported dates are provenance metadata and do not independently prove freshness.

Conflicting product names, pricing, and capabilities were not resolved by guessing. Securian's retrieved product page identifies Eclipse Accumulator IUL while the recommended product is Eclipse Accumulator II IUL, and the exact currently issued policy form varies by state. Ranking-stage labels also referenced Minnesota Life Eclipse IUL and SecureCare IUL, which the retrieved sources do not fully reconcile.

The supplied URLs were collected from platform responses and were not independently validated during the writing stage. No personalized premium, guaranteed illustration, or complete current charge schedule was publicly verified. No verified public evidence establishes current $2 million-plus issue limits or superior large-case underwriting execution for the exact recommended plan.

Company-owned citations materially outnumber independent citations in the supplied material. Financial-strength ratings are company-reported summaries of independent agency ratings and are subject to change. Ratings do not guarantee policy performance or claims payment.

One normalization note applies: one or more fetched domains were not corroborated by brand identity metadata and were not used as official identity signals, and company-name variants were collapsed onto one canonical brand before qualification.

Sources

Company-Owned Sources

Independent Sources

Other Sources

  • Insurance products issued by: Minnesota Life Insurance Company: http://docs.uuinc.com/news/Securian%20eclipse%20iul%20oregon.pdf
  • Additional AI research evidence113 records
    1. AI research evidence record anthropic:1-4
    2. AI research evidence record anthropic:1-5
    3. AI research evidence record perplexity:c1
    4. AI research evidence record perplexity:c6
    5. AI research evidence record openai:c3
    6. AI research evidence record anthropic:21-1
    7. AI research evidence record anthropic:21-7
    8. AI research evidence record anthropic:22-8
    9. AI research evidence record anthropic:16-3
    10. AI research evidence record anthropic:16-4
    11. AI research evidence record anthropic:40-1
    12. AI research evidence record anthropic:40-9
    13. AI research evidence record anthropic:40-16
    14. AI research evidence record openai:c1
    15. AI research evidence record anthropic:6-2
    16. AI research evidence record anthropic:6-4
    17. AI research evidence record perplexity:c5
    18. AI research evidence record perplexity:c8
    19. AI research evidence record anthropic:2-5
    20. AI research evidence record anthropic:2-6
    21. AI research evidence record anthropic:2-7
    22. AI research evidence record anthropic:32-2
    23. AI research evidence record anthropic:33-3
    24. AI research evidence record anthropic:12-2
    25. AI research evidence record anthropic:12-4
    26. AI research evidence record anthropic:35-12
    27. AI research evidence record anthropic:35-14
    28. AI research evidence record openai:c3
    29. AI research evidence record anthropic:20-5
    30. AI research evidence record anthropic:20-6
    31. AI research evidence record anthropic:21-1
    32. AI research evidence record anthropic:16-3
    33. AI research evidence record anthropic:16-4
    34. AI research evidence record openai:c1
    35. AI research evidence record anthropic:6-2
    36. AI research evidence record perplexity:c5
    37. AI research evidence record anthropic:40-9
    38. AI research evidence record anthropic:40-16
    39. AI research evidence record anthropic:40-17
    40. AI research evidence record openai:c2
    41. AI research evidence record anthropic:30-5
    42. AI research evidence record anthropic:30-7
    43. AI research evidence record perplexity:c11
    44. AI research evidence record anthropic:6-1
    45. AI research evidence record anthropic:6-3
    46. AI research evidence record anthropic:29-5
    47. AI research evidence record anthropic:18-12
    48. AI research evidence record anthropic:36-3
    49. AI research evidence record anthropic:12-12
    50. AI research evidence record anthropic:12-13
    51. AI research evidence record grok:2
    52. AI research evidence record anthropic:11-2
    53. AI research evidence record anthropic:11-10
    54. AI research evidence record anthropic:11-11
    55. AI research evidence record anthropic:35-6
    56. AI research evidence record anthropic:30-6
    57. AI research evidence record grok:1
    58. AI research evidence record kimi:pl-ph-iul2-2026
    59. AI research evidence record kimi:pru-momentum-iul-2026
    60. AI research evidence record kimi:jh-iul-guide-2026
    61. AI research evidence record anthropic:6-2
    62. AI research evidence record anthropic:6-4
    63. AI research evidence record perplexity:c5
    64. AI research evidence record openai:c1
    65. AI research evidence record openai:c2
    66. AI research evidence record anthropic:10-8
    67. AI research evidence record anthropic:35-16
    68. AI research evidence record perplexity:c12
    69. AI research evidence record anthropic:40-1
    70. AI research evidence record anthropic:40-3
    71. AI research evidence record anthropic:40-9
    72. AI research evidence record anthropic:40-13
    73. AI research evidence record anthropic:38-5
    74. AI research evidence record anthropic:12-2
    75. AI research evidence record anthropic:12-4
    76. AI research evidence record anthropic:35-12
    77. AI research evidence record anthropic:35-14
    78. AI research evidence record anthropic:35-15
    79. AI research evidence record anthropic:11-2
    80. AI research evidence record anthropic:11-11
    81. AI research evidence record anthropic:35-6
    82. AI research evidence record openai:c2
    83. AI research evidence record anthropic:30-5
    84. AI research evidence record perplexity:c4
    85. AI research evidence record anthropic:30-6
    86. AI research evidence record anthropic:30-7
    87. AI research evidence record grok:1
    88. AI research evidence record perplexity:c11
    89. AI research evidence record anthropic:18-12
    90. AI research evidence record anthropic:6-1
    91. AI research evidence record anthropic:6-3
    92. AI research evidence record anthropic:29-5
    93. AI research evidence record anthropic:11-2
    94. AI research evidence record anthropic:11-10
    95. AI research evidence record anthropic:11-11
    96. AI research evidence record openai:c3
    97. AI research evidence record anthropic:22-8
    98. AI research evidence record anthropic:40-9
    99. AI research evidence record anthropic:12-2
    100. AI research evidence record anthropic:35-14
    101. AI research evidence record anthropic:2-2
    102. AI research evidence record anthropic:3-3
    103. AI research evidence record anthropic:2-7
    104. AI research evidence record anthropic:32-2
    105. AI research evidence record anthropic:2-5
    106. AI research evidence record anthropic:2-6
    107. AI research evidence record anthropic:11-2
    108. AI research evidence record anthropic:11-10
    109. AI research evidence record anthropic:18-12
    110. AI research evidence record anthropic:36-3
    111. AI research evidence record anthropic:12-12
    112. AI research evidence record anthropic:30-6
    113. AI research evidence record grok:1

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 21, 2026
Platforms analyzed
7
Source records
46
Ranking mentions
4 of 7
Platform share
57%
Final consensus rank
#7

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

18 independent · 26 company-owned · 2 unclear

Evidence support

39 direct · 7 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

9830c5a5f1eaf1fbbca14be5345d053ef8938de5e90437fb532751b4038f89c2